2-bromo-N-(pyrazin-2-yl)acetamide → (R)-3-Hydroxy-1-(pyrazin-2-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2]octane bromide
Reaction equation
[Br-].[OH:2][C@@H:3]1[CH:8]2[CH2:9][CH2:10][N+:5]([CH2:11][C:12](=[O:19])[NH:13][C:14]3[CH:18]=CO[N:15]=3)([CH2:6][CH2:7]2)[CH2:4]1.[Br:20][CH2:21][C:22]([NH:24]C1C=NC=CN=1)=O>>[Br-:20].[OH:2][C@@H:3]1[CH:8]2[CH2:7][CH2:6][N+:5]([CH2:11][C:12](=[O:19])[NH:13][C:14]3[CH:18]=[N:24][CH:22]=[CH:21][N:15]=3)([CH2:10][CH2:9]2)[CH2:4]1Participants
3
Procedure
This compound is prepared by an analogous method to (R)-3-hydroxy-1-(isoxazol-3-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2]octane bromide (Intermediate A) by replacing 2-bromo-N-isoxazol-3-yl-acetamide with 2-bromo-N-pyrazin-2-yl-acetamide [H(i)].
Sources & evidence
- ORD record
- ord-b5e42565965a4fffabe34bcaca7248b0
- Source dataset
- uspto-grants-2010_05
- Patent number
- US07723356B2
Reaction notes
Loading…